Recombinant Cytomegalovirus Glycoprotein B (Fc Chimera) (ab256435)
Key features and details
- Expression system: HEK 293 cells
- Purity: > 95% SDS-PAGE
- Tags: Fc tag C-Terminus
- Suitable for: SDS-PAGE
Description
-
Product name
Recombinant Cytomegalovirus Glycoprotein B (Fc Chimera)
See all Cytomegalovirus Glycoprotein B proteins and peptides -
Purity
> 95 % SDS-PAGE. -
Expression system
HEK 293 cells -
Protein length
Protein fragment -
Animal free
No -
Nature
Recombinant -
-
Species
Cytomegalovirus -
Sequence
Strain: Human betaherpesvirus 5 towne strain. -
Predicted molecular weight
102 kDa -
Amino acids
1 to 700 -
Tags
Fc tag C-Terminus -
Additional sequence information
Recombinant gene product from HCMV UL55 locus. A glycine-serine linker and mouse IgG1 FC-tag was fused to aa 700. aa 457-460 were replaced with the sequence TTQT to prevent furin cleavage.
-
Specifications
Our Abpromise guarantee covers the use of ab256435 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
-
Applications
SDS-PAGE
-
Form
Liquid -
Concentration information loading...
Preparation and Storage
-
Stability and Storage
Shipped on Dry Ice. Store at -80°C. Avoid freeze / thaw cycle.
pH: 7
Constituent: PBS
Dulbecco's PBS
General Info
-
Alternative names
- CMV glycoprotein B
- Glycoprotein B
- HCMV
see all -
Relevance
Human cytomegalovirus (HCMV) glycoprotein B (gB) is an abundant virion envelope protein that has been shown to be essential for the infectivity of HCMV. HCMV gB is also one of the most immunogenic virus-encoded proteins, and a significant fraction of virus neutralizing antibodies are directed at gB. -
Cellular localization
Virus envelope.
Images
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
Datasheet download
References (0)
ab256435 has not yet been referenced specifically in any publications.